Hospira, Inc., a Pfizer company, recalled 8.4% Sodium Bicarbonate Injection USP. These products came from lot 56-148-EV, expiring August 1, 2017. The product is packaged 50 mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50mL, single-dose vials. The impacted vials may contain some form of particulate matter. If you think this recall affects you, stop using this product, and call the pharmacy that gave you the prescription. See the FDA website for more information about this recall.